Evidence map›Paper›PMID 39763770›Full record

ArticlebioRxiv : the preprint server for biology2025

IL-1β-driven NF-κB transcription of ACE2 as a Mechanism of Macrophage Infection by SARS-CoV-2.

Cadence Lee, Rachel Khan, Chris S Mantsounga, Sheila Sharma, Julia Pierce, Elizabeth Amelotte, Celia A Butler, Andrew Farinha, Crystal Parry, Olivya Caballero and 8 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Cadence LeeVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Rachel KhanVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Chris S MantsoungaVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Sheila SharmaVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Julia PierceVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Elizabeth AmelotteVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Celia A ButlerVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Andrew FarinhaVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Crystal ParryVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Olivya CaballeroVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Jeremi A MorrisonVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Saketh UppuluriVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Jeffrey J WhyteDepartment of Veterinary Pathobiology, University of Missouri College of Veterinary Medicine, Columbia, Missouri, USA.
Joshua L KennedyDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Xuming ZhangDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Gaurav ChoudharyVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.
Rachel M OlsonDepartment of Veterinary Pathobiology, University of Missouri College of Veterinary Medicine, Columbia, Missouri, USA.
Alan R MorrisonVascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island 02908, USA.ORCID 0000-0002-2412-7669

Funding

Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes MellitusP20GM103652 · NIGMS · OCEAN STATE RESEARCH INSTITUTE, INC. · PI CHOUDHARY, GAURAV, HARRINGTON, ELIZABETH O · 2013 to 2022
$21.3M
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment LaboratoryUC7AI180306 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI Rachel M Olson · 2023 to 2026
$12.1M
Pilot Projects ProgramP30GM149398 · NIGMS · OCEAN STATE RESEARCH INSTITUTE, INC. · PI Gaurav Choudhary · 2023 to 2026
$5.5M
Brown Respiratory Research Training ProgramT32HL134625 · NHLBI · BROWN UNIVERSITY · PI Elizabeth O Harrington, Sharon Irene Smith Rounds · 2017 to 2026
$5.1M
Center for Cancer Signaling NetworksP30GM103410 · NIGMS · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2012 to 2015
$4.3M
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the AgedR01HL163005 · NHLBI · OCEAN STATE RESEARCH INSTITUTE, INC. · PI MORRISON, ALAN ROSS · 2022 to 2025
$2.3M
Short-Term Training Program to Increase Diversity in Health-Related ResearchR25HL088992 · NHLBI · BROWN UNIVERSITY · PI ABID, RUHUL, DIAZ, JOSEPH A · 2007 to 2024
$1.9M
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific AtherosclerosisR01HL139795 · NHLBI · OCEAN STATE RESEARCH INSTITUTE, INC. · PI MORRISON, ALAN ROSS · 2018 to 2022
$1.8M
Role of Endothelial Anoctamin-1 in Pulmonary Arterial HypertensionR01HL148727 · NHLBI · OCEAN STATE RESEARCH INSTITUTE, INC. · PI CHOUDHARY, GAURAV · 2019 to 2022
$1.6M
Role of Skeletal Muscle Mitochondrial Supercomplexes in Exercise IntoleranceI01CX001892 · VA · PROVIDENCE VA MEDICAL CENTER · PI CHOUDHARY, GAURAV · 2019 to 2022
–
Reprogramming Macrophages to Improve Vascular Healing in DiabetesI01CX002231 · VA · PROVIDENCE VA MEDICAL CENTER · PI MORRISON, ALAN ROSS · 2021 to 2024
–
BLRD VA IK2 BX002527CSRD VA I01 CX001892CSRD VA I01 CX002231NHLBI NIH HHS R01 HL139795NHLBI NIH HHS R01 HL148727NHLBI NIH HHS R01 HL163005NHLBI NIH HHS R25 HL088992NHLBI NIH HHS T32 HL134625NIAID NIH HHS UC7 AI180306NIGMS NIH HHS P20 GM103652NIGMS NIH HHS P30 GM103410NIGMS NIH HHS P30 GM149398
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by infection with the enveloped RNA betacoronavirus, SARS-CoV-2, led to a global pandemic involving over 7 million deaths. Macrophage inflammatory responses impact COVID-19 severity; however, it is unclear whether macrophages are infected by SARS-CoV-2. We sought to identify mechanisms regulating macrophage expression of ACE2, the primary receptor for SARS-CoV-2, and to determine if macrophages are susceptible to productive infection. We developed a humanized

Indexed as

ACE2Animal ModelsCOVID-19Infectious DiseaseInflammationMacrophagesSARS-CoV-2

Identifiers

PMID39763770
PMCPMC11703209

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.